Advertisement
Screener

Canopy Growth Corp (CGC) Proceeds from Sale of Treasury Stock

Canopy Growth Corp Proceeds from Sale of Treasury Stock

Canopy Growth Corp (CGC) reported Proceeds from Sale of Treasury Stock of CAD 276.69 million for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfTreasuryStock · last filed 2026-02-06

  • Canopy Growth Corp proceeds from sale of treasury stock for the quarter ending 2025-12-31 was 0.00 CAD.

CAD

Period endProceeds from Sale of Treasury Stock 3 monthProceeds from Sale of Treasury Stock 6 monthProceeds from Sale of Treasury Stock 9 month
2025-12-310.00 CAD
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06
276.69M CAD
10-Q · filed 2026-02-06
2025-09-30276.69M CAD
10-Q · filed 2025-11-07

USD

Period endProceeds from Sale of Treasury Stock 3 monthProceeds from Sale of Treasury Stock 6 monthProceeds from Sale of Treasury Stock 9 month
2025-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06
$200.00M
10-Q · filed 2026-02-06
2025-09-30$200.00M
10-Q · filed 2025-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87